• Home
  • Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

About Aarti Pharmalabs Limited

Aarti Pharmalabs Limited (APL) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. We manufacture Generic APIs, Intermediates and Xanthine derivatives (Caffeine). We offer CDMO services for small molecules drug substances (API/NCE/RSM/Intermediate) process development and manufacturing focusing on clinical and commercial phase projects for Innovator companies. We have dedicated facilities to manufacture HPAPIs, Corticosteroids, Cytotoxic and Oncology products. 

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Contact info
Show contact info Hide contact info
Meet us at

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia
2 Jun 2026 - 4 June 2026
View Exhibitor Profile

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
View Exhibitor Profile

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

CPHI India 2026

IICC, Yashobhoomi, Dwarka, Delhi
23 Nov 2026 - 25 Nov 2026
View Exhibitor Profile

Products from Aarti Pharmalabs Limited (2)

  • API

    Product API

    CDMO, API, RSM, KSM, Generics, Xanthine
  • Generic API Product List

    Product Generic API Product List

    Our Active Pharmaceutical Ingredients (API) manufacturing facility in Maharashtra, has Genral API, corticosteroid and oncology API production blocks with US FDA and EU GMP accreditation. A strong backward integration strategy helps us maintain our leadership position. In the API segment where we produce th...